Senolytics

Trending/Senolytics

close up of Mayo Clinic Laboratories research hands with purple gloves holding a beaker and measuring a liquid

By Robert Nellis
June 8, 2021
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

Senolytics reduce COVID-19 symptoms in preclinical studies

ROCHESTER, Minn. — Mayo Clinic researchers and colleagues at the University of Minnesota showed that COVID-19 exacerbates the damaging impact of senescent cells in the body.…

By Robert Nellis
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

September 18, 2019

Mayo researchers demonstrate senescent cell burden is reduced in humans by senolytic drugs

By Robert Nellis
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

March 25, 2019

Removal of ‘zombie cells’ alleviates causes of diabetes in obese mice

By Robert Nellis
Share
- Facebook
- Twitter
- LinkedIn
- Email
- Print
Cancel

March 9, 2015

Mayo Clinic and Collaborators Find New Class of Drugs that Reduces Aging in Mice

Special Topics

Sign up

For Journalists Only Sign up for a Media Pass

Mayo Clinic Connect

An online patient support community

Trending/Senolytics

Senolytics reduce COVID-19 symptoms in preclinical studies

Special Topics

Cancer

Cardiovascular

Gastroenterology

Neurosciences

Transplant

Research

Mayo Clinic Minute

Healthy Living

Sports Medicine

Children's Center

Sign up